Xiao-Jun Huang (Xiao J Huang, Xiaojun Huang)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 107

Top Venues

Bone marrow transplantation

British journal of haematology

Leukemia

Leukemia & lymphoma

Peking-Tsinghua Center for Life Sciences

Beijing Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Peking-Tsinghua Center for Life Sciences Aug 1o 2012

China

Clinical Principal Investigator

Education History

Beijing Medical University Sep 1o 1987 - Jul 1o 1992

China

PHD

Publications

Yu-Qian Sun, Rui Ma, Xiao-Jun Huang
Optimizing the treatment of cytomegalovirus infection in allo-HSCT recipients. Expert review of clinical immunology 19 (2) (2023)
Fei-Fei Tang, Xiaosu Zhao, Guorui Ruan, Qian Jiang, Hao Jiang, Lanping Xu, Yu Wang, Xiaohui Zhang, Kaiyan Liu, Xiao-Jun Huang
The effect of haploidentical hematopoietic stem cell transplantation on comutations based on next-generation sequencing in adult acute myeloid leukemia patients with the FLT3-ITD mutation. Hematological oncology (2023)
Jun Wang, Kai Sun, Wen-Min Chen, Xu Wang, Ling-Di Li, Yue Hao, Nan Xu, Hao Jiang, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Xiao-Jun Huang, Qian Jiang, Ya-Zhen Qin
The prognostic significance of CRLF2 expression at diagnosis in adult Ph-negative B-cell precursor acute lymphoblastic leukemia. Leukemia & lymphoma 64 (3) (2023)
Yu-Qian Sun, Rui Ma, Xiao-Jun Huang
Optimizing the treatment of cytomegalovirus infection in allo-HSCT recipients. Expert review of clinical immunology 19 (2) (2023)
Jun Kong, Feng-Mei Zheng, Zhi-Dong Wang, Yuan-Yuan Zhang, Yi-Fei Cheng, Hai-Xia Fu, Meng Lv, Huan Chen, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Yu Wang
Avapritinib is effective for treatment of minimal residual disease in acute myeloid leukemia with t (8;21) and kit mutation failing to immunotherapy after allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation (2023)
Yu-Qian Sun, Xiao-Hui Zhang, Qian Jiang, Hao Jiang, Ying-Jun Chang, Yu Wang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang
Comparison of haploidentical hematopoietic stem cell transplantation with chemotherapy in older adults with acute myeloid leukemia. Bone marrow transplantation (2023)
Feiyang Qi, Xiao-Shuai Zhang, Robert Peter Gale, Bingcheng Liu, Jian Huang, Xiao-Jun Huang, Qian Jiang
External validation of the predictive scoring systems for molecular responses in chronic myeloid leukaemia receiving initial imatinib-therapy. Leukemia (2023)
Jun Wang, Kai Sun, Wen-Min Chen, Xu Wang, Ling-Di Li, Yue Hao, Nan Xu, Hao Jiang, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Xiao-Jun Huang, Qian Jiang, Ya-Zhen Qin
The prognostic significance of CRLF2 expression at diagnosis in adult Ph-negative B-cell precursor acute lymphoblastic leukemia. Leukemia & lymphoma 64 (3) (2023)
Zheng-Li Xu, Lan-Ping Xu, Yuan-Yuan Zhang, Yi-Fei Cheng, Xiao-Dong Mo, Ting-Ting Han, Feng-Rong Wang, Chen-Hua Yan, Yu-Qian Sun, Yu-Hong Chen, Fei-Fei Tang, Wei Han, Yu Wang, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang
Mixed chimaerism is associated with poorer long-term failure-free survival among aplastic anaemia patients receiving HLA-matched donor transplantation. Bone marrow transplantation (2023)
Ya-Lan Zhou, Ming-Yue Zhao, Robert Peter Gale, Hao Jiang, Qian Jiang, Li-Xia Liu, Jia-Yue Qin, Shan-Bo Cao, Feng Lou, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Guo Rui Ruan
Mutations in DEAD/H-box helicase 11 correlate with increased relapse risk in adults with acute myeloid leukaemia with normal cytogenetics. Leukemia (2023)
Xiaolu Zhu, Qian Jiang, Jin Lu, Yuqian Sun, Xiaosu Zhao, Shenmiao Yang, Fei-Fei Tang, Wenjing Yu, Ting Zhao, Xiaohong Liu, Jin-Song Jia, Wenbing Duan, Lijuan Hu, Jing Wang, Yang Liu, Nan Peng, Xuelin Dou, Rui Ma, Qiang Fu, Huifang Wang, Xin-Xin Liu, Xiao-Jun Huang, Hao Jiang
COVID-19 infection in patients with haematological malignancies: A single-centre survey in the latest Omicron wave in China. British journal of haematology (2023)
Yu-Qian Sun, Rui Ma, Xiao-Jun Huang
Optimizing the treatment of cytomegalovirus infection in allo-HSCT recipients. Expert review of clinical immunology 19 (2) (2023)
Xiao-Shuai Zhang, Robert Peter Gale, Bingcheng Liu, Jian Huang, Yanli Zhang, Xin Du, Jianyu Weng, Weiming Li, Na Xu, Xiaoli Liu, Chunyan Chen, Hai Lin, Guohui Li, Rong Liang, Zhuogang Liu, Xiaodong Wang, Yanqing Zhang, Yanqiu Han, Chunshui Liu, Jian-da Hu, Lie Lin, Wei Yang, Zhenfang Liu, Li Meng, Chuanqing Tu, Caifeng Zheng, Zeping Zhou, Yanliang Bai, Huiying Qiu, Suning Chen, Fei Li, Jianxin Guo, Zelin Liu, Hui Sun, Li Zhou, Ru Feng, Xiuli Sun, Xiao-Jun Huang, Qian Jiang
Validation of the imatinib-therapy failure model. Leukemia (2023)
Xiaolu Zhu, Qian Jiang, Jin Lu, Yuqian Sun, Xiaosu Zhao, Shenmiao Yang, Fei-Fei Tang, Wenjing Yu, Ting Zhao, Xiaohong Liu, Jin-Song Jia, Wenbing Duan, Lijuan Hu, Jing Wang, Yang Liu, Nan Peng, Xuelin Dou, Rui Ma, Qiang Fu, Huifang Wang, Xin-Xin Liu, Xiao-Jun Huang, Hao Jiang
COVID-19 infection in patients with haematological malignancies: A single-centre survey in the latest Omicron wave in China. British journal of haematology (2023)
Zhi-Wei Zhang, Xiao-Su Zhao, Huidong Guo, Xiao-Jun Huang
The role of m 6 A demethylase FTO in chemotherapy resistance mediating acute myeloid leukemia relapse. Cell death discovery 9 (1) (2023)
Jun Wang, Kai Sun, Wen-Min Chen, Xu Wang, Ling-Di Li, Yue Hao, Nan Xu, Hao Jiang, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Xiao-Jun Huang, Qian Jiang, Ya-Zhen Qin
The prognostic significance of CRLF2 expression at diagnosis in adult Ph-negative B-cell precursor acute lymphoblastic leukemia. Leukemia & lymphoma (2023)
Yu-Qian Sun, Rui Ma, Xiao-Jun Huang
Optimizing the treatment of cytomegalovirus infection in allo-HSCT recipients. Expert review of clinical immunology (2023)
Le-Qing Cao, Wen-Xuan Huo, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Xiao-Jun Huang, Xiao-Dong Mo
Peripheral blood stem cell transplantation from haploidentical related donor could achieve satisfactory clinical outcomes for intermediate- or high-risk adult acute myeloid leukemia patients. Bone marrow transplantation (2023)
Xiaolu Zhu, Qian Jiang, Jin Lu, Yuqian Sun, Xiaosu Zhao, Shenmiao Yang, Fei-Fei Tang, Wenjing Yu, Ting Zhao, Xiaohong Liu, Jin-Song Jia, Wenbing Duan, Lijuan Hu, Jing Wang, Yang Liu, Nan Peng, Xuelin Dou, Rui Ma, Qiang Fu, Huifang Wang, Xin-Xin Liu, Xiao-Jun Huang, Hao Jiang
COVID-19 infection in patients with haematological malignancies: A single-centre survey in the latest Omicron wave in China. British journal of haematology (2023)
Junbin Huang, Bo Feng, Yifei Cheng, Lanping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Yu Wang
Unmanipulated haploidentical hematopoietic stem cell transplantation for mixed phenotype acute leukemia: a single center study. Bone marrow transplantation (2023)
Jun Wang, Kai Sun, Wen-Min Chen, Xu Wang, Ling-Di Li, Yue Hao, Nan Xu, Hao Jiang, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Xiao-Jun Huang, Qian Jiang, Ya-Zhen Qin
The prognostic significance of CRLF2 expression at diagnosis in adult Ph-negative B-cell precursor acute lymphoblastic leukemia. Leukemia & lymphoma 64 (3) (2023)
Lan-Ping Xu, Zheng-Li Xu, Yuan-Yuan Zhang, Yi-Fei Cheng, Xiao-Dong Mo, Ting-Ting Han, Feng-Rong Wang, Chen-Hua Yan, Yu-Qian Sun, Yu-Hong Chen, Fei-Fei Tang, Wei Han, Yu Wang, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang
Bulsufan decreases the incidence of mixed chimaerism in HLA-matched donor transplantation for severe aplastic anaemia. Bone marrow transplantation 57 (7) (2022)
Ting Huang, Lan-Ping Xu, Xiao-Hui Zhang, Yingjun Chang, Xiao-Dong Mo, Yuqian Sun, Xiao-Jun Huang, Yu Wang
Haploidentical haematopoietic stem cell transplantation for TP53-mutated acute myeloid leukaemia. British journal of haematology (2022)
Xiao-Shuai Zhang, Robert Peter Gale, Zi-Yu Li, Meng-Yu Zhang, Xiao-Jun Huang, Qian Jiang
Predictive scoring systems for molecular responses in persons with chronic phase chronic myeloid leukemia receiving initial imatinib therapy. Leukemia 36 (8) (2022)
Chen-Hua Yan, Yu Wang, Yu-Qian Sun, Yi-Fei Cheng, Xiao-Dong Mo, Feng-Rong Wang, Yu-Hong Chen, Yuan-Yuan Zhang, Ting-Ting Han, Huan Chen, Lan-Ping Xu, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang
Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long-term clinical outcomes and health-related quality of life assessment. Cancer communications (London, England) (2022)
Kai-Yan Liu, Ying Liu, Junfang Yang, Xian Zhang, Xiao Yang, Hui Wang, Lin Wang, Qinglong Wang, David Jin, Jianqiang Li, Xiao-Jun Huang
Naturally selected CD7 CAR-T therapy without genetic manipulations for T-ALL/LBL: first-in-human phase 1 clinical trial. Blood 140 (4) (2022)
Yu Wang, Yuan Kong, Hong-Yan Zhao, Yuan-Yuan Zhang, Ya-Zhe Wang, Lan-Ping Xu, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang
Prophylactic NAC promoted hematopoietic reconstitution by improving endothelial cells after haploidentical HSCT: a phase 3, open-label randomized trial. BMC medicine 20 (1) (2022)
Sen Yang, Xiao-Shuai Zhang, Robert Peter Gale, Xiao-Jun Huang, Qian Jiang
Co-variates associated with outcomes of tyrosine kinase-inhibitor therapy in persons with chronic myeloid leukaemia initially presenting in accelerated phase. Leukemia 36 (7) (2022)
Xue-Yi Luo, Yuan Kong, Meng Lv, Xiao-Dong Mo, Yu Wang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Fei-Fei Tang
The nuclear factor erythroid 2-related factor 2 agonist tert-butylhydroquinone improves bone marrow mesenchymal stromal cell function in prolonged isolated thrombocytopenia after allogeneic haematopoietic stem cell transplantation. British journal of haematology (2022)
Si-Qi Li, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han, Yu-Qian Sun, Chen-Hua Yan, Meng Lv, Fei-Fei Tang, Xiao-Dong Mo, Yan-Rong Liu, Kai-Yan Liu, Ying-Jun Chang, Xiao-Jun Huang
An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study. Blood 140 (5) (2022)
Xu-Ying Pei, Xiang-Yu Zhao, Xue-Fei Liu, Xiao-Dong Mo, Meng Lv, Lan-Ping Xu, Yu Wang, Ying-Jun Chang, Xiao-Hui Zhang, Xin-Xin Liu, Xiao-Jun Huang
Adoptive therapy with cytomegalovirus-specific T cells for cytomegalovirus infection after haploidentical stem cell transplantation and factors affecting efficacy. American journal of hematology 97 (6) (2022)
Zheng-Li Xu, Xiao-Jun Huang
Optimizing allogeneic grafts in hematopoietic stem cell transplantation. Stem cells translational medicine (2022)
Yu-Qian Sun, Rui Ma, Xiao-Jun Huang
Optimizing the treatment of cytomegalovirus infection in allo-HSCT recipients. Expert review of clinical immunology (2022)
Huidong Guo, Ruifeng Li, Ming Wang, Yingping Hou, Shuoshuo Liu, Ting Peng, Xiang-Yu Zhao, Liming Lu, Yali Han, Yiming Shao, Ying-Jun Chang, Cheng Li, Xiao-Jun Huang
Multiomics Analysis Identifies SOCS1 as Restraining T Cell Activation and Preventing Graft-Versus-Host Disease. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (21) (2022)
Xiao-Dong Mo, Shen-Da Hong, Yan-Li Zhao, Er-Lie Jiang, Jing Chen, Yang Xu, Zi-Min Sun, Wei-Jie Zhang, Qi-Fa Liu, Dai-Hong Liu, Ding-Ming Wan, Wen-Jian Mo, Han-Yun Ren, Ting Yang, He Huang, Xi Zhang, Xiao-Ning Wang, Xian-Min Song, Su-Jun Gao, Xin Wang, Yi Chen, Bing Xu, Ming Jiang, Xiao-Bing Huang, Xin Li, Hong-Yu Zhang, Hong-Tao Wang, Zhao Wang, Ting Niu, Ji-Shi Wang, Ling-Hui Xia, Xiao-Dan Liu, Fei Li, Fang Zhou, Tao Lang, Jiong Hu, Sui-Jing Wu, Xiao-Jun Huang
Basiliximab for steroid-refractory acute graft-versus-host disease: A real-world analysis. American journal of hematology 97 (4) (2022)
Xiao-Shuai Zhang, Robert Peter Gale, Mei-Jie Zhang, Xiao-Jun Huang, Qian Jiang
A predictive scoring system for therapy-failure in persons with chronic myeloid leukemia receiving initial imatinib therapy. Leukemia 36 (5) (2022)
Arnon Nagler, Myriam Labopin, Xiao-Jun Huang, Didier Blaise, William Arcese, Mercedes Colorado Araujo, Gerard Sociè, Edouard Forcade, Fabio Ciceri, Jonathan Canaani, Sebastian Giebel, Eolia Brissot, Jaime Sanz Caballer, Ali Bazarbachi, Ibrahim Yakoub Agha, Mohamad Mohty
Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMT. Bone marrow transplantation 57 (4) (2022)
Ming Wang, Bixia Wang, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Yi-Fei Cheng, Yu-Qian Sun, Yuan-Yuan Zhang, Yan-Rong Liu, Ying-Jun Chang, Kai-Yan Liu, Xiao-Jun Huang
The lower relapse rate and better survival advantages of haploidentical allograft compared with HLA-matched sibling donor allografts for intermediate- and adverse-risk AML patients with pretransplantation minimal residual disease. Bone marrow transplantation (2022)
Lan-Ping Xu, Yue Lu, Jing Chen, Shuwen Sun, Shaoyan Hu, Shunqing Wang, Xuedong Wu, Yuan Sun, Dingming Wan, Yajing Xu, Hui Jiang, Chun-Fu Li, Mei Lan, Erlie Jiang, Fei Li, Sixi Liu, Yongmin Tang, Fan Lin, Peihua Lu, Chengjuan Luo, Xiao-Jun Huang, null null
Fludarabine- and low-dose cyclophosphamide-based conditioning regimens provided favorable survival and engraftment for unmanipulated hematopoietic cell transplantation from unrelated donors and matched siblings in patients with Fanconi anemia: results from the CBMTR. Bone marrow transplantation (2022)
Fei-Fei Tang, Sheng-Ye Lu, Xiao-Su Zhao, Ya-Zhen Qin, Xiao-Hong Liu, Jin-Song Jia, Jing Wang, Li-Zhong Gong, Qian Jiang, Ting Zhao, Hong-Xia Shi, Ying-Jun Chang, Xiao-Jun Huang, Hao Jiang
PML-RARA transcript levels at the end of induction therapy are associated with prognosis in non-high-risk acute promyelocytic leukaemia with all-trans retinoic acid plus arsenic in front-line therapy: long-term follow-up of a single-centre cohort study. British journal of haematology 195 (5) (2021)
Lan-Ping Xu, Pei-Hua Lu, De-Pei Wu, Zi-Min Sun, Qi-Fa Liu, Ming-Zhe Han, Xi Zhang, Yong-Ping Song, Xian-Min Song, Jian-da Hu, He Huang, Yong-Rong Lai, Ding-Ming Wan, Jing Chen, Chun-Fu Li, Ling-Hui Xia, Jing-Bo Wang, Dai-Hong Liu, Xiao-Jun Huang, null null
Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group. Bone marrow transplantation 56 (12) (2021)
Xiang Wang, Xue-Fei Liu, Qian-Nan Shang, Xing-Xing Yu, Ze-Ying Fan, Xun-Hong Cao, Ming-Rui Huo, Ying-Jun Chang, Xiao-Su Zhao, Yu Wang, Xiao-Hui Zhang, Lan-Ping Xu, Xin-Xin Liu, Xiao-Jun Huang, Xiang-Yu Zhao
Donor activating killer cell immunoglobulin-like receptors genes correlated with Epstein-Barr virus reactivation after haploidentical haematopoietic stem cell transplantation. British journal of haematology (2021)
Yejun Wu, Hui Liu, Qiao-Zhu Zeng, Yi Liu, Jing-Wen Wang, Wen-Sheng Wang, Jia Feng, He-Bing Zhou, Qiu-Sha Huang, Yun He, Hai-Xia Fu, Xiao-Lu Zhu, Qian Jiang, Hao Jiang, Ying-Jun Chang, Lan-Ping Xu, Xiao-Jun Huang, Xiao-Hui Zhang
All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP. Blood (2021)
Run-Qing Lu, Li-Xin Wu, Jing Zhang, Ya-Zhen Qin, Yan-Rong Liu, Yue-Yun Lai, Hao Jiang, Ying-Jun Chang, Guo-Rui Ruan, Xiao-Jun Huang
Prognostic value of RASD1 transcript levels in adult Philadelphia-negative B-cell acute lymphoblastic leukemia. Hematology (Amsterdam, Netherlands) 26 (1) (2021)
Xiao-Hui Zhang, Jing Chen, Ming-Zhe Han, He Huang, Er-Lie Jiang, Ming Jiang, Yong-Rong Lai, Dai-Hong Liu, Qi-Fa Liu, Ting Liu, Han-Yun Ren, Yong-Ping Song, Zi-Min Sun, Xiao-Wen Tang, Jian-Min Wang, De-Pei Wu, Lan-Ping Xu, Xi Zhang, Dao-Bin Zhou, Xiao-Jun Huang
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. Journal of hematology & oncology 14 (1) (2021)
Xiang-Yu Zhao, Zheng-Li Xu, Xiao-Dong Mo, Yu-Hong Chen, Meng Lv, Yi-Fei Cheng, Huan Chen, Ying-Jun Chang, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang
Preemptive donor-derived anti-CD19 CAR T-cell infusion showed a promising anti-leukemia effect against relapse in MRD-positive B-ALL after allogeneic hematopoietic stem cell transplantation. Leukemia (2021)
Zhengli Xu, Xiao-Jun Huang
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives. Cancer biology & medicine (2021)
Ya-Zhen Qin, Qian Jiang, Yu Wang, Hao Jiang, Lan-Ping Xu, Xiao-Su Zhao, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang
The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia. Blood cancer journal 11 (4) (2021)
Zheng-Li Xu, Xiao-Jun Huang
Optimizing outcomes for haploidentical hematopoietic stem cell transplantation in severe aplastic anemia with intensive GVHD prophylaxis: a review of current findings. Expert review of hematology 14 (5) (2021)
Hong-Yan Zhao, Yuan-Yuan Zhang, Tong Xing, Shu-Qian Tang, Qi Wen, Zhong-Shi Lyu, Meng Lv, Yu Wang, Lan-Ping Xu, Xiao-Hui Zhang, Yuan Kong, Xiao-Jun Huang
M2 macrophages, but not M1 macrophages, support megakaryopoiesis by upregulating PI3K-AKT pathway activity. Signal transduction and targeted therapy 6 (1) (2021)
Jiangying Liu, Haitao Gao, Lan-Ping Xu, Xiao-Dong Mo, Ruoyang Liu, Shuang Liang, Ning Wu, Ming Wang, Zhidong Wang, Ying-Jun Chang, Yu Wang, Xiao-Hui Zhang, Xiao-Jun Huang
Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2+ T cells activities after hematopoietic transplantation for blood malignancies. Journal for immunotherapy of cancer 8 (1) (2021)
Hao Jiang, Xiao-Hong Liu, Kong Jun, Jing Wang, Jin-Song Jia, Sheng-Ye Lu, Li-Zhong Gong, Xiao-Jun Huang, Qian Jiang, Ying-Jun Chang, Yu Wang, Guo-Rui Ruan, Ya-Zhen Qin, Kai-Yan Liu, Xiao-Jun Huang
Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia. Leukemia & lymphoma 62 (12) (2021)
Peng Zhao, Yejun Wu, Yun He, Shan Chong, Qingyuan Qu, Ruixin Deng, Xiaowan Sun, Qiu-Sha Huang, Xiao Liu, Xiaolu Zhu, Fengrong Wang, Yuanyuan Zhang, Xiaodong Mo, Wei Han, JingZhi Wang, Yu Wang, Huan Chen, Yuhong Chen, Xiangyu Zhao, Ying-Jun Chang, Lan-Ping Xu, Kaiyan Liu, Xiao-Jun Huang, Xiao-Hui Zhang
A prognostic model (BATAP) with external validation for patients with transplant-associated thrombotic microangiopathy. Blood advances (2021)
Fei-Fei Tang, Xiang-Yu Zhao, Ming-Rui Huo, Ying-Jun Chang, Wei Han, Yu-Hong Chen, Chen-Hua Yan, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Yu Wang
Comparison of the clinical outcomes between NIMA-mismatched and NIPA-mismatched haploidentical hematopoietic stem cell transplantation for patients with hematological malignancies. Bone marrow transplantation 56 (11) (2021)
Xiao-Shuai Zhang, Robert Peter Gale, Xiao-Jun Huang, Qian Jiang
Is the Sokal or EUTOS long-term survival (ELTS) score a better predictor of responses and outcomes in persons with chronic myeloid leukemia receiving tyrosine-kinase inhibitors? Leukemia (2021)
Yang Liu, Yueyun Lai, Ling Ma, Lei Wen, Wenbing Duan, Fengrong Wang, Ying Kang, Huan Chen, Yao Chen, Lu Gao, Xiao-Jun Huang, Jin Lu
Fluorescence in situ hybridisation combined with CD138 immunomagnetic sorting is effective to identify cytogenetic abnormalities which play significant prognostic roles in Chinese AL amyloidosis patients. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 27 (3) (2020)
Zheng-Li Xu, Xiao-Jun Huang
Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges. Bone marrow transplantation 56 (4) (2020)
Meng Lv, Qian Jiang, Dao-Bin Zhou, Yu Hu, Dai-Hong Liu, De-Pei Wu, Jing-Bo Wang, Hao Jiang, Jing Wang, Ying-Jun Chang, Yu Wang, Xiao-Hui Zhang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang
Comparison of haplo-SCT and chemotherapy for young adults with standard-risk Ph-negative acute lymphoblastic leukemia in CR1. Journal of hematology & oncology 13 (1) (2020)
Yuan Kong, Yu Wang, Yuan-Yuan Zhang, Min-Min Shi, Xiao-Dong Mo, Yu-Qian Sun, Ying-Jun Chang, Lan-Ping Xu, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang
Prophylactic oral NAC reduced poor hematopoietic reconstitution by improving endothelial cells after haploidentical transplantation. Blood advances 3 (8) (2020)
Zheng-Li Xu, Xiao-Jun Huang
COVID-19 & Allogeneic Transplant: Activity and Preventive Measures for Best Outcomes in China. Advances in cell and gene therapy (2020)
Ying-Jun Chang, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han, Yu-Qian Sun, Chen-Hua Yan, Fei-Fei Tang, Ming-Rui Huo, Xiang-Yu Zhao, Xiao-Dong Mo, Kai-Yan Liu, Xiao-Jun Huang
Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody. Bone marrow transplantation 55 (7) (2020)
Xin-Xin Liu, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Dong Mo
Prognostic factors and long-term follow-up of basiliximab for steroid-refractory acute graft-versus-host disease: Updated experience from a large-scale study. American journal of hematology 95 (8) (2020)
Qi Wen, Hong-Yan Zhao, Wei-Li Yao, Yuan-Yuan Zhang, Hai-Xia Fu, Yu Wang, Lan-Ping Xu, Xiao-Hui Zhang, Yuan Kong, Xiao-Jun Huang
Monocyte subsets in bone marrow grafts may contribute to a low incidence of acute graft-vs-host disease for young donors. Journal of cellular and molecular medicine 24 (16) (2020)
Zi-Long Wang, Yang Liu, Ya-Lan Zhou, Jin-Lan Li, Qiu-Yu Sun, Li-Xin Wu, Lei Wen, Yue-Yun Lai, Yan-Rong Liu, Ying-Jun Chang, Hong-Xia Shi, Xin-Xin Liu, Xiao-Jun Huang, Jin Lu, Guo Rui Ruan
Osteoclast stimulatory transmembrane protein (OC-STAMP) is a promising molecular prognostic indicator for multiple myeloma. European journal of haematology 105 (2) (2020)
Le-Qing Cao, Meng Lv, Lan-Ping Xu, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han, Yu-Qian Sun, Chen-Hua Yan, Fei-Fei Tang, Xiao-Dong Mo, Kai-Yan Liu, Xiao-Jun Huang, Ying-Jun Chang
Prevalence and risk factors of having antibodies to class I and II human leukocyte antigens in older haploidentical allograft candidates. Scientific reports 10 (1) (2020)
Yan-Ru Ma, Wen-Jing Wang, Yi-Fei Cheng, Yuan-Yuan Zhang, Xiao-Dong Mo, Ting-Ting Han, Feng-Rong Wang, Chen-Hua Yan, Yu-Qian Sun, Yu-Hong Chen, Jing-Zhi Wang, Fei-Fei Tang, Wei Han, Yu Wang, Xiao-Hui Zhang, Xiao-Jun Huang, Lan-Ping Xu
Impact of ABO incompatibility on outcomes after haploidentical hematopoietic stem cell transplantation for severe aplastic anemia. Bone marrow transplantation 55 (6) (2020)
Chen-Hua Yan, Yu Wang, Xiao-Dong Mo, Yu-Qian Sun, Feng-Rong Wang, Hai-Xia Fu, Yao Chen, Ting-Ting Han, Jun Kong, Yi-Fei Cheng, Xiao-Hui Zhang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang
Incidence, risk factors, and outcomes of cytomegalovirus retinitis after haploidentical hematopoietic stem cell transplantation. Bone marrow transplantation 55 (6) (2020)
Florent Malard, Xiao-Jun Huang, Joycelyn P Y Sim
Treatment and unmet needs in steroid-refractory acute graft-versus-host disease. Leukemia 34 (5) (2020)
Wenbing Duan, Xiaohong Liu, Jinsong Jia, Jing Wang, Lizhong Gong, Qian Jiang, Ting Zhao, Yu Wang, Xiaohui Zhang, Lanping Xu, Xiaosu Zhao, Yazhen Qin, Hongxia Shi, Yingjun Chang, Xiao-Jun Huang, Hao Jiang
The loss or absence of minimal residual disease of <0·1% at any time after two cycles of consolidation chemotherapy in CBFB-MYH11-positive acute myeloid leukaemia indicates poor prognosis. British journal of haematology 192 (2) (2020)
Shenmiao Yang, Abraham M Varghese, Nitin Sood, Carlos Chiattone, Norah O Akinola, Xiao-Jun Huang, Robert Peter Gale
Ethnic and geographic diversity of chronic lymphocytic leukaemia. Leukemia 35 (2) (2020)
Lan-Ping Xu, Shun-Qing Wang, Yan-Ru Ma, Su-Jun Gao, Yi-Fei Cheng, Yuan-Yuan Zhang, Wen-Jian Mo, Xiao-Dong Mo, Yu-Ping Zhang, Chen-Hua Yan, Yu-Hong Chen, Ming Zhou, Yu Wang, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang
Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study. Journal of hematology & oncology 12 (1) (2019)
Dao-Xing Deng, Hong-Hu Zhu, Yan-Rong Liu, Ying-Jun Chang, Guo-Rui Ruan, Jin-Song Jia, Hao Jiang, Qian Jiang, Xiao-Su Zhao, Xiao-Jun Huang
Minimal residual disease detected by multiparameter flow cytometry is complementary to genetics for risk stratification treatment in acute myeloid leukemia with biallelic CEBPA mutations. Leukemia & lymphoma 60 (9) (2019)
Zheng-Li Xu, Lan-Ping Xu, Yuan-Yuan Zhang, Yi-Fei Cheng, Xiao-Dong Mo, Feng-Rong Wang, Yu-Hong Chen, Wei Han, Chen-Hua Yan, Yu-Qian Sun, Ting-Ting Han, Yu Wang, Xiao-Hui Zhang, Xiao-Jun Huang
Incidence and predictors of severe cardiotoxicity in patients with severe aplastic anaemia after haploidentical haematopoietic stem cell transplantation. Bone marrow transplantation 54 (10) (2019)
Yu-Juan Xue, Pan Suo, Xiao-Jun Huang, Ai-Dong Lu, Yu Wang, Ying-Xi Zuo, Chen-Hua Yan, Jun Wu, Jun Kong, Xiao-Hui Zhang, Yu-Hong Chen, Yue-Ping Jia, Xin-Xin Liu, Wei Han, Lan-Ping Xu, Le-Ping Zhang, Yi-Fei Cheng
Superior survival of unmanipulated haploidentical haematopoietic stem cell transplantation compared with intensive chemotherapy as post-remission treatment for children with very high-risk philadelphia chromosome negative B-cell acute lymphoblastic leukaemia in first complete remission. British journal of haematology 188 (5) (2019)
Zheng-Li Xu, Ming Zhou, Jin-Song Jia, Wen-Jian Mo, Xiao-Hui Zhang, Yu-Ping Zhang, Yu Wang, Yu-Miao Li, Xiao-Jun Huang, Shun-Qing Wang, Lan-Ping Xu
Immunosuppressive therapy versus haploidentical transplantation in adults with acquired severe aplastic anemia. Bone marrow transplantation 54 (8) (2019)
Yu Wang, Qi-Fa Liu, De-Pei Wu, Lan-Ping Xu, Kai-Yan Liu, Xiao-Hui Zhang, Sheng-Ye Lu, Xiao Ma, Fen Huang, Xiao-Jun Huang
Improved survival after offspring donor transplant compared with older aged-matched siblings for older leukaemia patients. British journal of haematology 189 (1) (2019)
Yang Liu, Lei Wen, Ling Ma, Ying Kang, Xin-Xin Liu, Xiao-Jun Huang, Guo-Rui Ruan, Jin Lu
MAGE genes: Prognostic indicators in AL amyloidosis patients. Journal of cellular and molecular medicine 23 (8) (2019)
Meng Lv, Ke Wang, Xiao-Jun Huang
Myeloid-derived suppressor cells in hematological malignancies: friends or foes. Journal of hematology & oncology 12 (1) (2019)
Meng Lv, Shu-Zhen Zhai, Yu Wang, Lan-Ping Xu, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han, Yu-Qian Sun, Yi-Fei Cheng, Chen-Hua Yan, Xiao-Dong Mo, Kai-Yan Liu, Ying-Jun Chang, Xiao-Jun Huang, Xiang-Yu Zhao
Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factors. Bone marrow transplantation 54 (8) (2019)
Yu Wang, De-Pei Wu, Qi-Fa Liu, Lan-Ping Xu, Kai-Yan Liu, Xiao-Hui Zhang, Wen-Jing Yu, Yang Xu, Fen Huang, Xiao-Jun Huang
Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients. Journal of hematology & oncology 12 (1) (2019)
Qi Wen, Yuan Kong, Hong-Yan Zhao, Yuan-Yuan Zhang, Ting-Ting Han, Yu Wang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang
G-CSF-induced macrophage polarization and mobilization may prevent acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation 54 (9) (2019)
Stefan O Ciurea, Monzr M Al Malki, Piyanuch Kongtim, Ephraim J Fuchs, Leo Luznik, Xiao-Jun Huang, Fabio Ciceri, Franco Locatelli, Franco Aversa, Luca Castagna, Andrea Bacigalupo, Massimo Martelli, Didier Blaise, Patrick Ben Soussan, Yolande Arnault, Rupert Handgretinger, Denis-Claude Roy, Paul V O'Donnell, Asad Bashey, Scott Solomon, Rizwan Romee, Jorge Gayoso, Hillard M Lazarus, Karen Ballen, Bipin N Savani, Mohamad Mohty, Arnon Nagler
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation. Bone marrow transplantation 55 (1) (2019)
Ke Wang, Meng Lv, Ying-Jun Chang, Xiang-Yu Zhao, Xiao-Su Zhao, Yuan-Yuan Zhang, Yu-Qian Sun, Zhi-Dong Wang, Pan Suo, Yang Zhou, Dan Liu, Shu-Zhen Zhai, Yan Hong, Yu Wang, Xiao-Hui Zhang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang
Early myeloid-derived suppressor cells (HLA-DR-/lowCD33+CD16-) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCT. Journal of hematology & oncology 12 (1) (2019)
Xiao-Jun Huang, Yan-Rong Liu, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Wei Han, Yu-Qian Sun, Chen-Hua Yan, Xiao-Dong Mo, Ya-Zhe Wang, Qiao-Zhen Fan, Xin-Yu Wang, Xin-Xin Liu, Xiao-Jun Huang, Ying-Jun Chang
Minimal residual disease status determined by multiparametric flow cytometry pretransplantation predicts the outcome of patients with ALL receiving unmanipulated haploidentical allografts. American journal of hematology 94 (5) (2019)
Xiao-Su Zhao, Xiao-Jun Huang
Seeking biomarkers for acute graft-versus-host disease: where we are and where we are heading? Biomarker research 7 (2019)
Yuan-Yuan Zhang, Xiao-Dong Mo, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Yu-Qian Sun, Kai-Yan Liu, Xiao-Jun Huang
FLT3 internal tandem duplication does not impact prognosis after haploidentical allogeneic hematopoietic stem cell transplantation in AML patients. Bone marrow transplantation 54 (9) (2019)
Ya-Zhen Qin, Qian Jiang, Hao Jiang, Yue-Yun Lai, Hong-Xia Shi, Wen-Min Chen, Lu Yu, Xiao-Jun Huang
Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre. British journal of haematology 182 (5) (2018)
Jonathan Canaani, Myriam Labopin, Xiao-Jun Huang, Fabio Ciceri, Maria T Van Lint, Benedetto Bruno, Stella Santarone, José L Diez-Martin, Didier Blaise, Patrizia Chiusolo, Depei Wu, Mohamad Mohty, Arnon Nagler
Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T-cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT). British journal of haematology 183 (3) (2018)
Wei Sun, Xiao-Dong Mo, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Kai-Yan Liu, Xiao-Jun Huang
Chemotherapy plus DLI for relapse after haploidentical HSCT: the biological characteristics of relapse influences clinical outcomes of acute leukemia patients. Bone marrow transplantation 54 (8) (2018)
Yuan Kong, Yang Song, Fei-Fei Tang, Hong-Yan Zhao, Yu-Hong Chen, Wei Han, Chen-Hua Yan, Yu Wang, Xiao-Hui Zhang, Lan-Ping Xu, Xiao-Jun Huang
N-acetyl-L-cysteine improves mesenchymal stem cell function in prolonged isolated thrombocytopenia post-allotransplant. British journal of haematology 180 (6) (2018)
Ming-Rui Huo, Xu-Ying Pei, Dan Li, Ying-Jun Chang, Lan-Ping Xu, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang
Impact of HLA allele mismatch at HLA-A, -B, -C, -DRB1, and -DQB1 on outcomes in haploidentical stem cell transplantation. Bone marrow transplantation 53 (5) (2018)
Yao Chen, Jin Lu, Lan-Ping Xu, Huan Chen, Xiao-Hui Zhang, Feng-Rong Wang, Yu-Hong Chen, Yu Wang, Kai-Yan Liu, Xiao-Jun Huang
Safety and efficacy of haploidentical stem cell transplantation for multiple myeloma. Bone marrow transplantation 53 (4) (2018)
Yao Chen, Lan-Ping Xu, Xiao-Hui Zhang, Huan Chen, Feng-Rong Wang, Kai-Yan Liu, Jiong Qin, Yan-Ling Yang, Xiao-Jun Huang
Busulfan, Fludarabine, and Cyclophosphamide (BFC) conditioning allowed stable engraftment after haplo-identical allogeneic stem cell transplantation in children with adrenoleukodystrophy and mucopolysaccharidosis. Bone marrow transplantation 53 (6) (2018)
Ya-Zhen Qin, Hong Hu Zhu, Qian Jiang, Lan-Ping Xu, Hao Jiang, Yu Wang, Xiao-Su Zhao, Yan-Rong Liu, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang
Heterogeneous prognosis among KIT mutation types in adult acute myeloid leukemia patients with t(8;21). Blood cancer journal 8 (8) (2018)
Xie-Na Cao, Yuan Kong, Yang Song, Min-Min Shi, Hong-Yan Zhao, Qi Wen, Zhong-Shi Lyu, Cai-Wen Duan, Yu Wang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang
Impairment of bone marrow endothelial progenitor cells in acute graft-versus-host disease patients after allotransplant. British journal of haematology 182 (6) (2018)
Yang Liu, Lanping Xu, Xiaohui Zhang, Yu Wang, Kaiyan Liu, Huan Chen, Yuhong Chen, Wei Han, Chenhua Yan, Xiao-Jun Huang
Acute kidney injury following haplo stem cell transplantation: incidence, risk factors and outcome. Bone marrow transplantation 53 (4) (2018)
Fei-Fei Tang, Xiao-Dong Mo, Yu Wang, Chen-Hua Yan, Yu-Hong Chen, Huan Chen, Wei Han, Ying-Jun Chang, Hai-Ying Zhang, Yan-Di Xie, Hui Ma, Lai Wei, Lan-Ping Xu, Xiao-Jun Huang, Xiao-Hui Zhang
Hepatitis E virus infection after haploidentical haematopoietic stem cell transplantation: incidence and clinical course. British journal of haematology 184 (5) (2018)
Yuan Kong, Min-Min Shi, Yuan-Yuan Zhang, Xie-Na Cao, Yu Wang, Xiao-Hui Zhang, Lan-Ping Xu, Xiao-Jun Huang
N-acetyl-L-cysteine improves bone marrow endothelial progenitor cells in prolonged isolated thrombocytopenia patients post allogeneic hematopoietic stem cell transplantation. American journal of hematology 93 (7) (2018)
Yu-Qian Sun, Ying-Jun Chang, Xiao-Jun Huang
Update on current research into haploidentical hematopoietic stem cell transplantation. Expert review of hematology 11 (4) (2018)
Jingru Zhang, Yingqiao Wang, Jianxiang Wang, Jianda Hu, Suning Chen, Jie Jin, Ting Liu, Jianfeng Zhou, Yu Hu, Daoxin Ma, Xiao-Jun Huang, Chunyan Ji, Ming Hou
Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance. Blood cancer journal 8 (7) (2018)

Xiao-Jun Huang.css-eqlu8i{font-size:small;padding-left:4px;} (Xiao J Huang, Xiaojun Huang)

Publication Activity (10 Years)

Top Topics

Top Venues

Xiao-Jun Huang (Xiao J Huang, Xiaojun Huang)